COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,220 Articles (22,733 medRxiv, 8,487 bioRxiv)

Most recent first Previous |  Page 2155: Articles 21541-21550  | Next

Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS-CoV-2 infection in vitro
Rescher, U., Schloer, S., Brunotte, L., Mecate-Zambrano, A., Zheng, S., Tang, J., Ludwig, S.
10.1101/2020.10.16.342410 — Posted: 2020-10-16
How to remove the testing bias in CoV-2 statistics
Waelde, K.
10.1101/2020.10.14.20212431 — Posted: 2020-10-16
Early Prediction of COVID-19 Severity Using Extracellular Vesicles and Extracellular RNAs
Fujita, Y., Hoshina, T., Matsuzaki, J., Kadota, T., Fujimoto, S., Kawamoto, H., Watanabe, N., Sawaki, K., Sakamoto, Y., Miyajima, M., Lee, K., Nakaharai, K., Horino, T., Nakagawa, R., Araya, J., Miyato, M., Yoshida, M., Kuwano, K., Ochiya, T.
10.1101/2020.10.14.20212340 — Posted: 2020-10-16
The effect of influenza vaccination on trained immunity: impact on COVID-19
Debisarun, P. A., Struycken, P., Dominguez-Andres, J., Moorlag, S. J. C. F. M., Taks, E., Gössling, K. L., Ostermann, P. N., Müller, L., Schaal, H., ten Oever, J., van Crevel, R., Netea, M. G.
10.1101/2020.10.14.20212498 — Posted: 2020-10-16 Discussion: Onsite | Offsite
A betacoronavirus multiplex microsphere immunoassay detects early SARS-CoV-2 seroconversion and controls for pre-existing seasonal human coronavirus antibody cross-reactivity
Laing, E. D., Sterling, S. L., Richard, S. A., Phogat, S., Samuels, E. C., Epsi, N. J., Yan, L., Moreno, N., Coles, C., Mehalko, J., Drew, M., English, C., Chung, K. K., Clifton, G. T., Munster, V., de Wit, E., Tribble, D., Agan, B., Esposito, D., Lanteri, C., Mitre, E., Burgess, T. H., Broder, C. C.
10.1101/2020.10.14.20207050 — Posted: 2020-10-16
Multi-organ impairment in low-risk individuals with long COVID
Dennis, A., Wamil, M., Kapur, S., Alberts, J., Badley, A., Decker, G. A., Rizza, S. A., Banerjee, R., Banerjee, A.
10.1101/2020.10.14.20212555 — Posted: 2020-10-16 Discussion: Onsite | Offsite
CoViD-19, learning from the past: A wavelet and cross-correlation analysis of the epidemic dynamics looking to emergency calls and Twitter trends in Italian Lombardy region
Rivieccio, B. A., Micheletti, A., Maffeo, M., Zignani, M., Comunian, A., Nicolussi, F., Salini, S., Manzi, G., Auxilia, F., Giudici, M., Naldi, G., Gaito, S., Castaldi, S., Biganzoli, E.
10.1101/2020.10.14.20212415 — Posted: 2020-10-16 Discussion: Offsite
On Modeling of COVID-19 for the Indian Subcontinent using Polynomial and Supervised Learning Regression
Neve, D., Patel, H., Dhiman, H. S.
10.1101/2020.10.14.20212563 — Posted: 2020-10-16
Title: COVID-19 and frontline health workers in West Africa: a scoping review
Pereko, K. K. A., Ameyaw, E. K., Bukari, S., Acquaye, V., Dai-Kosi, A. D.
10.1101/2020.10.15.20213249 — Posted: 2020-10-16
Understanding the value of clinical symptoms of COVID-19. A logistic regression model
Fleitas, P. E., Paz, J. A., Simoy, M. I., Vargas, C., Cimino, R. O., Krolewiecki, A. J., Aparicio, J. P.
10.1101/2020.10.07.20207019 — Posted: 2020-10-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).